Ardelyx (ARDX) Cash & Equivalents Growth (3y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -51.77% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | 24.73% |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -28.55% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | 13.33% |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | -16.07% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 21.66% |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -8.88% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 36.53% |
| 10 | Ardelyx | 1.48 Bn | 1.25 Bn | 89.66 Mn | -30.38% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -30.38% |
| Dec 31, 2025 | -10.90% |
| Sep 30, 2025 | -11.50% |
| Jun 30, 2025 | 19.02% |
| Mar 31, 2025 | -13.18% |
| Dec 31, 2024 | -3.58% |
| Sep 30, 2024 | -14.28% |
| Jun 30, 2024 | -21.54% |
| Mar 31, 2024 | -24.52% |
| Dec 31, 2023 | -38.22% |
| Sep 30, 2023 | -28.14% |
| Jun 30, 2023 | -33.12% |
| Mar 31, 2023 | -4.41% |
| Dec 31, 2022 | -19.03% |
| Sep 30, 2022 | -12.71% |
| Jun 30, 2022 | -15.85% |
| Mar 31, 2022 | -20.03% |
| Dec 31, 2021 | -2.76% |
| Sep 30, 2021 | 0.12% |
| Jun 30, 2021 | -1.85% |
| Mar 31, 2021 | 7.46% |
| Dec 31, 2020 | 6.49% |
| Sep 30, 2020 | 15.25% |
| Jun 30, 2020 | 16.45% |
| Mar 31, 2020 | 14.14% |
| Dec 31, 2019 | 34.41% |
| Sep 30, 2019 | -16.70% |
| Jun 30, 2019 | -15.14% |
| Mar 31, 2019 | -18.76% |
| Dec 31, 2018 | -9.71% |
| Sep 30, 2018 | -16.54% |
| Jun 30, 2018 | -13.45% |
| Mar 31, 2018 | -11.68% |
| Dec 31, 2017 | -11.10% |
| Sep 30, 2017 | -19.04% |
| Jun 30, 2017 | -18.56% |
| Mar 31, 2017 | 28.94% |
| Dec 31, 2016 | 29.39% |
| Sep 30, 2016 | 89.60% |
| Jun 30, 2016 | 83.47% |